Trials / Completed
CompletedNCT02549976
Evaluation of Digestive Damage and Associated Predictive Factors in Crohn's Disease 5 to 10 Years After Diagnosis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 54 (actual)
- Sponsor
- Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective is to evaluate digestive damage in CD 5 to 10 years after diagnosis in the GETAID centers included in the RAPID study. Secondary objective is to identify predictive factors of the evolution digestive damage.
Detailed description
Background: Crohn's disease (CD) is a chronic inflammatory disorder of the bowel that is characterized by periods of clinical remission alternating with periods of recurrence. Persistent inflammation is believed to lead to progressive bowel damage that, over time, will manifest in the development of strictures, fistulae, and abscesses. The recent development of the Lemann index allows us to precisely assess digestive damage in CD. The aim of the present study is to evaluate digestive damage and associated predictive factors in CD 5 to 10 years after diagnosis. Methods: Prospective, multicenter, international, transversal, observational study. Patients who completed the RAPID trial (evaluating the benefits on the course of CD of an early prescription of azathioprine compared with conventional step-care therapy) will be eligible. Digestive damage will be assessed using methods described in the Lemann index protocol, dependent on CD location (abdominal MRI obligatory). The total duration of study participation for 1patient will be ≤4 months. Aims: The primary objective is to evaluate digestive damage in CD 5 to 10 years after diagnosis in the GETAID centers included in the RAPID study. Secondary objective is to identify predictive factors of the evolution digestive damage.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Abdominal MRI | Abdominal MRI to realize within 4 months following inclusion |
| PROCEDURE | Upper endoscopy | Upper endoscopy to realize within 4 months following inclusion |
| PROCEDURE | Colonoscopy | Colonoscopy to realize within 4 months following inclusion |
| PROCEDURE | Pelvic MRI | Pelvic MRI to realize within 4 months following inclusion |
Timeline
- Start date
- 2015-12-01
- Primary completion
- 2018-02-01
- Completion
- 2018-02-01
- First posted
- 2015-09-15
- Last updated
- 2018-07-31
Locations
9 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02549976. Inclusion in this directory is not an endorsement.